Celyad Oncology

+$0.07 (+3.90%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYAD and other ETFs, options, and stocks.

About CYAD

Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology.

CEO
Filippo Joseph Petti
Employees
103
Headquarters
Mont-Saint-Guibert, Walloon Region
Founded
2007

CYAD Key Statistics

Market cap
45.19M
Price-Earnings ratio
—
Dividend yield
—
Average volume
6.81K
High today
$2.00
Low today
$1.88
Open price
$1.88
Volume
19.87K
52 Week high
$6.40
52 Week low
$1.51

CYAD Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Available Aug 5
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure